NEUROPACE, INC. Net Income
NEUROPACE, INC. (NPCE) reported Net Income of -$6.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-11
- NEUROPACE, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$6.20M.
- NEUROPACE, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$6.69M.
- NEUROPACE, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$2.73M.
- NEUROPACE, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$3.50M.
- NEUROPACE, INC. net income (loss) attributable to parent for fiscal 2025 was -$21.46M.
- NEUROPACE, INC. net income (loss) attributable to parent for fiscal 2024 was -$27.14M.
- NEUROPACE, INC. net income (loss) attributable to parent for fiscal 2023 was -$32.96M.
- NEUROPACE, INC. net income (loss) attributable to parent for fiscal 2022 was -$47.08M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.20M 10-Q · filed 2026-08-11 | -$12.89M 10-Q · filed 2026-08-11 | -$15.62M derived: sum of 3 quarters · filed 2026-08-11 | -$19.11M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$6.69M 10-Q · filed 2026-08-11 | -$9.42M derived: sum of 2 quarters · filed 2026-08-11 | -$12.91M derived: sum of 3 quarters · filed 2026-08-11 | -$21.57M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$6.22M derived: sum of 2 quarters · filed 2026-03-03 | -$14.88M derived: sum of 3 quarters · filed 2026-08-11 | -$21.46M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$3.50M 10-Q · filed 2025-11-04 | -$12.15M derived: sum of 2 quarters · filed 2026-08-11 | -$18.74M 10-Q · filed 2025-11-04 | -$23.99M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$8.65M 10-Q · filed 2026-08-11 | -$15.24M 10-Q · filed 2026-08-11 | -$20.49M derived: sum of 3 quarters · filed 2026-08-11 | -$25.94M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$6.59M 10-Q · filed 2026-08-11 | -$11.84M derived: sum of 2 quarters · filed 2026-08-11 | -$17.29M derived: sum of 3 quarters · filed 2026-08-11 | -$24.80M derived: sum of 4 quarters · filed 2026-08-11 |
| 2024-12-31 | -$5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$10.70M derived: sum of 2 quarters · filed 2026-03-03 | -$18.22M derived: sum of 3 quarters · filed 2026-03-03 | -$27.14M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$5.45M 10-Q · filed 2025-11-04 | -$12.97M derived: sum of 2 quarters · filed 2025-11-04 | -$21.89M 10-Q · filed 2025-11-04 | -$28.09M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$7.51M 10-Q · filed 2025-11-04 | -$16.44M 10-Q · filed 2025-08-12 | -$22.64M derived: sum of 3 quarters · filed 2025-11-04 | -$29.90M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-03-31 | -$8.93M 10-Q · filed 2025-11-04 | -$15.13M derived: sum of 2 quarters · filed 2025-11-04 | -$22.38M derived: sum of 3 quarters · filed 2025-11-04 | -$31.51M derived: sum of 4 quarters · filed 2025-11-04 |
| 2023-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$13.46M derived: sum of 2 quarters · filed 2025-03-04 | -$22.58M derived: sum of 3 quarters · filed 2025-03-04 | -$32.96M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$7.26M 10-Q · filed 2024-11-12 | -$16.38M derived: sum of 2 quarters · filed 2024-11-12 | -$26.76M 10-Q · filed 2024-11-12 | -$37.90M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$9.12M 10-Q · filed 2024-11-12 | -$19.50M 10-Q · filed 2024-08-13 | -$30.64M derived: sum of 3 quarters · filed 2024-11-12 | -$42.43M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-03-31 | -$10.38M 10-Q · filed 2024-11-12 | -$21.52M derived: sum of 2 quarters · filed 2024-11-12 | -$33.31M derived: sum of 3 quarters · filed 2024-11-12 | -$46.00M derived: sum of 4 quarters · filed 2024-11-12 |
| 2022-12-31 | -$11.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$22.93M derived: sum of 2 quarters · filed 2024-03-05 | -$35.62M derived: sum of 3 quarters · filed 2024-03-05 | -$47.08M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$11.79M 10-Q · filed 2023-11-06 | -$24.48M derived: sum of 2 quarters · filed 2023-11-06 | -$35.94M 10-Q · filed 2023-11-06 | -$46.63M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | -$12.69M 10-Q · filed 2023-11-06 | -$24.15M 10-Q · filed 2023-08-08 | -$34.84M derived: sum of 3 quarters · filed 2023-11-06 | -$42.93M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-03-31 | -$11.46M 10-Q · filed 2023-11-06 | -$22.15M derived: sum of 2 quarters · filed 2023-11-06 | -$30.24M derived: sum of 3 quarters · filed 2023-11-06 | -$38.73M derived: sum of 4 quarters · filed 2023-11-06 |
| 2021-12-31 | -$10.69M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$18.78M derived: sum of 2 quarters · filed 2023-03-02 | -$27.27M derived: sum of 3 quarters · filed 2023-03-02 | -$36.08M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$8.08M 10-Q · filed 2022-11-08 | -$16.58M derived: sum of 2 quarters · filed 2022-11-08 | -$25.39M 10-Q · filed 2022-11-08 | -$30.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$8.49M 10-Q · filed 2022-11-08 | -$17.30M 10-Q · filed 2022-08-11 | -$21.92M derived: sum of 3 quarters · filed 2022-11-08 | -$26.05M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-03-31 | -$8.81M 10-Q · filed 2022-11-08 | -$13.43M derived: sum of 2 quarters · filed 2022-11-08 | -$17.55M derived: sum of 3 quarters · filed 2022-11-08 | -$26.35M derived: sum of 4 quarters · filed 2022-11-08 |
| 2020-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$8.74M derived: sum of 2 quarters · filed 2022-03-10 | -$17.54M derived: sum of 3 quarters · filed 2022-03-10 | -$24.28M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$4.13M 10-Q · filed 2021-11-10 | -$12.92M derived: sum of 2 quarters · filed 2021-11-10 | -$19.66M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$8.79M 10-Q · filed 2021-11-10 | -$15.53M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$6.74M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |